- Kawasaki Disease and Coronary Complications
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Financial Risk and Volatility Modeling
- COVID-19 Impact on Reproduction
- Coronary Interventions and Diagnostics
- Methodologies in Health Research and Practice
- Immunodeficiency and Autoimmune Disorders
- Acute Lymphoblastic Leukemia research
- Complex Systems and Time Series Analysis
- Financial Markets and Investment Strategies
- Autoimmune and Inflammatory Disorders Research
- Inflammation biomarkers and pathways
Universidade Federal do Rio de Janeiro
2022
Universidade de São Paulo
2022
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2021
Hospital Federal dos Servidores do Estado
2019
To prospectively evaluate demographic, anthropometric and health-related quality of life (HRQoL) in pediatric patients with laboratory-confirmed coronavirus disease 2019 (COVID-19).
Background: Knowledge of the effect SARS-CoV-2 on innate and adaptive immune responses children is currently lacking. We investigated profile recovered pediatric patients 3 to 11 weeks after acute COVID-19. Methods: Children who were previously healthy or had a preexisting chronic disease positive reverse transcription polymerase chain reaction/serology enrolled (n=23). The control group was composed 25 without COVID-19 paired by age, sex baseline conditions. performed immunophenotyping,...
This paper expands the model for higher-order moments (evolving into an MVSK with skewness and kurtosis analysis) compares it to classic quadratic objective function of Markowitz. Along analysis, we add information entropy variable taking account asset's informational efficiency diversity, trying encompass high uncertainty intrinsic market's returns increase model's validity. We analyze practical effectiveness complexity creating such a multi-objective portfolio see if can provide more...
Macrophage Activation Syndrome (MAS) is a life-threatening condition associated with many conditions, including rheumatic diseases. Due to the rarity of MAS Systemic Lupus Erythematosus (SLE) most data available from single cases reports.